dehydroepiandrosterone has been researched along with Hemochromatosis in 4 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Hemochromatosis: A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diurnal variations of plasma testosterone and urinary excretion rates of testosterone-, androsterone-, aetiocholanolone-, and DHA-glucuronide, as well as DHA-sulphate were measured before and after selective Leydig-cell stimulation (with 3 X 5000 IU human gonadotrophin) in eight patients with alcoholic liver cirrhosis, ten with acute hepatitis and four with haemochromatosis." | 3.65 | [Androgen metabolism and Leydig-cell function in acute and chronic liver disease (author's transl)]. ( Gerdes, H; Littmann, KP; Martini, GA, 1975) |
| "Besides marked bone loss, hypogonadotropic hypogonadism was found in 3 male patients, while normal LH, FSH concentration values were measured in 3 female patients." | 1.28 | Is dehydroepiandrosterone-sulphate a possible pathogenetic factor in osteopenia of patients with iron overload? ( Czink, E; Horváth, C; Malek, AA; Siklósi, G, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okano, J | 1 |
| Yanase, T | 1 |
| Takayanagi, R | 1 |
| Mimura, K | 1 |
| Nawata, H | 1 |
| Littmann, KP | 1 |
| Gerdes, H | 1 |
| Martini, GA | 1 |
| Czink, E | 2 |
| Horváth, C | 2 |
| Malek, AA | 2 |
| Siklósi, G | 2 |
1 review available for dehydroepiandrosterone and Hemochromatosis
| Article | Year |
|---|---|
[Calcipenic osteopathy in transfusion hemosiderosis and idiopathic hemochromatosis].
Topics: Adult; Bone Diseases, Metabolic; Calcitonin; Calcium; Dehydroepiandrosterone; Female; Hemochromatosi | 1991 |
3 other studies available for dehydroepiandrosterone and Hemochromatosis
| Article | Year |
|---|---|
[Isolated gonadotropin deficiency and secretory discrepancy of cortisol and adrenal androgen by hemochromatosis secondary to congenital dyserythropoietic anemia].
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Anemia, Dyserythropoietic, Congenital; Dehydroep | 1994 |
[Androgen metabolism and Leydig-cell function in acute and chronic liver disease (author's transl)].
Topics: Acute Disease; Adult; Aged; Androgens; Androsterone; Chorionic Gonadotropin; Chronic Disease; Circad | 1975 |
Is dehydroepiandrosterone-sulphate a possible pathogenetic factor in osteopenia of patients with iron overload?
Topics: Adult; Bone Density; Bone Diseases, Metabolic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfat | 1991 |